Operating Expenses Cambiamento Data
AbbVie USD 11.11B 540M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Biogen USD 2.03B 344.1M 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Cytokinetics USD 129.09M 6.45M 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
J&J USD 16.57B 435M 2023-12
Merck USD 16.56B 6.35B 2023-12
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Xencor USD 79.7M 2.27M 2023-12



Xencor Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.